Clinical Trial Update: Zalutumumab in Combination With Chemo-Radiation in a Certain Type of Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating zalutumumab in combination with chemotherapy and radiotherapy for non-small cell lung cancer was terminated; results were posted in D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-12-05